| 1/2 | US=69 / Câncer Zurita AJ, Ward JF, Kim J. Targeted therapy in prostate cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 289-304. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER DE PROSTATA; CANCER DE PROSTATA; NEOPLASIA DE PROSTATA; RESISTENTE A CASTRACAO CANCRO DA PROSTATA; ANDROGENO RECEPTOS; ANSAMICINAS; MTOR; ANGIOGENESE; IMUNOTERAPIA |
| 2/2 | US=90 / Biol/Mol Xu W, Neckers L. EGFR signaling networks: differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 63-71. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CHAPERONES MOLECULARES; PROTEINA DE CHOQUE TERMICO 90; ANSAMICINAS BENZOQUINONA; GELDANAMICINA; HSP90 INIBIDOR; MUTACOES DE EGFR; SENSIBILIDADE AO FARMACO |